Matches in Wikidata for { <http://www.wikidata.org/entity/Q80087467> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q80087467 description "artículu científicu espublizáu n'agostu de 2006" @default.
- Q80087467 description "scientific article published on 08 August 2006" @default.
- Q80087467 description "wetenschappelijk artikel" @default.
- Q80087467 description "наукова стаття, опублікована в серпні 2006" @default.
- Q80087467 name "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 name "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 type Item @default.
- Q80087467 label "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 label "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 prefLabel "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 prefLabel "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 P1433 Q80087467-169F3F5F-F36D-4956-A45A-BB252160D624 @default.
- Q80087467 P1476 Q80087467-0BD8B633-126A-49AE-9456-5579CFC11E35 @default.
- Q80087467 P2093 Q80087467-4928B624-9D58-4013-BB88-6732D4EF7362 @default.
- Q80087467 P2093 Q80087467-663D93D6-65A0-4EE5-A4DB-8D61792CB024 @default.
- Q80087467 P2093 Q80087467-7E7AAE25-3C59-41A4-989A-6C25E3B98B91 @default.
- Q80087467 P2093 Q80087467-89C84283-78CE-4978-BE45-3170DE8C900A @default.
- Q80087467 P2093 Q80087467-B3BE5831-67D6-4053-BAE6-C0DE2CF45CB3 @default.
- Q80087467 P2093 Q80087467-EF0FF5D1-A421-4A37-8714-0BFACEDC31EE @default.
- Q80087467 P304 Q80087467-020007E6-7EF0-4143-9417-E681D350704B @default.
- Q80087467 P31 Q80087467-2DD3FA3F-04F3-4020-A32C-EE80F034F160 @default.
- Q80087467 P356 Q80087467-064B6A00-6706-4B79-974A-8D089FD82C1D @default.
- Q80087467 P433 Q80087467-81B85A20-9290-4C3A-8AA3-4AAF849F9EC0 @default.
- Q80087467 P478 Q80087467-91619F0B-0830-4F95-BB64-47B4FE4D1047 @default.
- Q80087467 P577 Q80087467-9671A61B-1231-49B0-A9F5-1271FB4F0CC7 @default.
- Q80087467 P698 Q80087467-F82FCD64-A82C-42CD-8240-CBDDBA426FA1 @default.
- Q80087467 P921 Q80087467-F3E3DF8C-B694-48C0-BB32-2FC7B6A5E5A6 @default.
- Q80087467 P356 J.EJCA.2006.05.018 @default.
- Q80087467 P698 16899362 @default.
- Q80087467 P1433 Q332260 @default.
- Q80087467 P1476 "Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies" @default.
- Q80087467 P2093 "Daines CA" @default.
- Q80087467 P2093 "Dalgleish AG" @default.
- Q80087467 P2093 "Knight RD" @default.
- Q80087467 P2093 "O'Byrne KJ" @default.
- Q80087467 P2093 "Sharma RA" @default.
- Q80087467 P2093 "Steward WP" @default.
- Q80087467 P304 "2318-2325" @default.
- Q80087467 P31 Q13442814 @default.
- Q80087467 P356 "10.1016/J.EJCA.2006.05.018" @default.
- Q80087467 P433 "14" @default.
- Q80087467 P478 "42" @default.
- Q80087467 P577 "2006-08-08T00:00:00Z" @default.
- Q80087467 P698 "16899362" @default.
- Q80087467 P921 Q5452194 @default.